Bellicum Pharmaceuticals, Inc (BLCM)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
02-Sep-22 10:30 AM
View: 
Davis Stephen
Director
Bellicum Pharmaceuticals, Inc (BLCM) 01-Sep-22Option Exercise 43,400----232%
18.71K to 62.12K
02-Sep-22 10:30 AM
View: 
Daly James M
Director
Bellicum Pharmaceuticals, Inc (BLCM) 01-Sep-22Option Exercise 35,082----244%
14.38K to 49.46K
02-Sep-22 10:26 AM
View: 
Stonehouse Jon P
Director
Bellicum Pharmaceuticals, Inc (BLCM) 01-Sep-22Option Exercise 60,580----141%
43.11K to 103.69K
02-Sep-22 10:29 AM
View: 
Huber Reid M
Director
Bellicum Pharmaceuticals, Inc (BLCM) 01-Sep-22Option Exercise 46,489----238%
19.49K to 65.98K
02-Sep-22 10:30 AM
View: 
Klimovsky Judith V
Director
Bellicum Pharmaceuticals, Inc (BLCM) 01-Sep-22Option Exercise 35,082----240%
14.6K to 49.68K
06-Jan-22 9:40 AM
View: 
Stonehouse Jon P
Director
Bellicum Pharmaceuticals, Inc (BLCM) 04-Jan-22Option Exercise 21,504----2150%
1.0K to 22.5K
06-Jan-22 9:51 AM
View: 
Huber Reid M
Director
Bellicum Pharmaceuticals, Inc (BLCM) 04-Jan-22Option Exercise 19,494----100%
0 to 19.49K
06-Jan-22 9:34 AM
View: 
Klimovsky Judith V
Director
Bellicum Pharmaceuticals, Inc (BLCM) 04-Jan-22Option Exercise 14,602----100%
0 to 14.6K
06-Jan-22 9:49 AM
View: 
Brown James F
Director
Bellicum Pharmaceuticals, Inc (BLCM) 04-Jan-22Option Exercise 28,384----100%
0 to 28.38K
06-Jan-22 9:31 AM
View: 
Davis Stephen
Director
Bellicum Pharmaceuticals, Inc (BLCM) 04-Jan-22Option Exercise 18,715----100%
0 to 18.71K
06-Jan-22 9:39 AM
View: 
Daly James M
Director
Bellicum Pharmaceuticals, Inc (BLCM) 04-Jan-22Option Exercise 14,377----100%
0 to 14.38K
02-Jun-20 12:25 PM
View: 
Ward Shane
Sr VP and Chief Legal SO
Bellicum Pharmaceuticals, Inc (BLCM) 29-May-20Payment of Exercise 107$7.63$816.41(5%)
1.99K to 1.88K
53%
19-Mar-20 12:48 PM
View: 
Fair Richard A.
President and CEO
Director
Bellicum Pharmaceuticals, Inc (BLCM) 17-Mar-20Market Purchase 5,000$4.00$19,998.5073%
6.81K to 11.81K
(10%)
06-Jan-20 5:00 PM
View: 
Smith Alan K.
EVP, Technical Operations
Bellicum Pharmaceuticals, Inc (BLCM) 03-Jan-20Payment of Exercise 589$1.40$824.60(8%)
7.54K to 6.96K
74%
06-Jan-20 4:29 PM
View: 
Foster Aaron E.
Sr VP, Head of Research
Bellicum Pharmaceuticals, Inc (BLCM) 03-Jan-20Option Exercise 625----9%
6.89K to 7.52K
06-Jan-20 5:15 PM
View: 
Williams Rosemary Y.
VP, Finance & PAO
Bellicum Pharmaceuticals, Inc (BLCM) 03-Jan-20Option Exercise 781----15%
5.27K to 6.05K
06-Jan-20 4:29 PM
View: 
Foster Aaron E.
Sr VP, Head of Research
Bellicum Pharmaceuticals, Inc (BLCM) 03-Jan-20Payment of Exercise 236$1.40$330.40(3%)
7.52K to 7.28K
74%
06-Jan-20 5:00 PM
View: 
Smith Alan K.
EVP, Technical Operations
Bellicum Pharmaceuticals, Inc (BLCM) 03-Jan-20Option Exercise 1,563----26%
5.98K to 7.54K
06-Jan-20 5:15 PM
View: 
Williams Rosemary Y.
VP, Finance & PAO
Bellicum Pharmaceuticals, Inc (BLCM) 03-Jan-20Payment of Exercise 295$1.40$413.00(5%)
6.05K to 5.76K
74%
06-Jan-20 4:29 PM
View: 
Foster Aaron E.
Sr VP, Head of Research
Bellicum Pharmaceuticals, Inc (BLCM) 02-Jan-20Option Exercise 2,500----47%
5.33K to 7.83K
06-Jan-20 5:15 PM
View: 
Williams Rosemary Y.
VP, Finance & PAO
Bellicum Pharmaceuticals, Inc (BLCM) 02-Jan-20Option Exercise 1,282----29%
4.47K to 5.75K
06-Jan-20 4:29 PM
View: 
Foster Aaron E.
Sr VP, Head of Research
Bellicum Pharmaceuticals, Inc (BLCM) 02-Jan-20Payment of Exercise 942$1.51$1,422.42(12%)
7.83K to 6.89K
76%
06-Jan-20 5:00 PM
View: 
Smith Alan K.
EVP, Technical Operations
Bellicum Pharmaceuticals, Inc (BLCM) 02-Jan-20Option Exercise 2,344----52%
4.52K to 6.87K
06-Jan-20 5:15 PM
View: 
Williams Rosemary Y.
VP, Finance & PAO
Bellicum Pharmaceuticals, Inc (BLCM) 02-Jan-20Payment of Exercise 483$1.51$729.33(8%)
5.75K to 5.27K
76%
06-Jan-20 5:00 PM
View: 
Smith Alan K.
EVP, Technical Operations
Bellicum Pharmaceuticals, Inc (BLCM) 02-Jan-20Payment of Exercise 883$1.51$1,333.33(13%)
6.87K to 5.98K
76%
14-Nov-19 5:11 PM
View: 
Woodard Jr Joseph Paul
SVP Clinical & Medical Affairs
Bellicum Pharmaceuticals, Inc (BLCM) 13-Nov-19Option Exercise 3,750----113%
3.31K to 7.06K
14-Nov-19 5:11 PM
View: 
Woodard Jr Joseph Paul
SVP Clinical & Medical Affairs
Bellicum Pharmaceuticals, Inc (BLCM) 13-Nov-19Payment of Exercise 1,597$0.82$1,309.54(23%)
7.06K to 5.47K
56%
11-Sep-19 7:01 PM
View: 
Fair Richard A.
President and CEO
Director
Bellicum Pharmaceuticals, Inc (BLCM) 10-Sep-19Market Purchase 40,000$1.25$50,000.00151%
26.56K to 66.56K
(71%)
30-Aug-19 4:01 PM
View: 
Ward Shane
Sr. VP and General Counsel
Bellicum Pharmaceuticals, Inc (BLCM) 29-Aug-19Market Purchase 8,000$1.23$9,821.6078%
10.29K to 18.29K
(71%)
23-Aug-19 4:03 PM
View: 
Fair Richard A.
President and CEO
Director
Bellicum Pharmaceuticals, Inc (BLCM) 21-Aug-19Market Purchase 20,000$0.99$19,780.00305%
6.56K to 26.56K
(63%)
23-Aug-19 4:04 PM
View: 
Naeve Gregory S.
Chief Business Officer
Bellicum Pharmaceuticals, Inc (BLCM) 21-Aug-19Payment of Exercise 1,597$0.95$1,513.48(10%)
15.34K to 13.75K
62%
30-May-19 4:05 PM
View: 
Ward Shane
Sr. VP and General Counsel
Bellicum Pharmaceuticals, Inc (BLCM) 29-May-19Payment of Exercise 1,065$2.09$2,225.85(11%)
10.0K to 8.94K
83%
07-Feb-19 4:02 PM
View: 
Grossman William
Sr. VP, Chief Medical Officer
Bellicum Pharmaceuticals, Inc (BLCM) 05-Feb-19Payment of Exercise 3,126$3.48$10,878.50(10%)
30.0K to 26.87K
90%
04-Jan-19 4:03 PM
View: 
Williams Rosemary Y.
Principal Accounting Officer
Bellicum Pharmaceuticals, Inc (BLCM) 03-Jan-19Option Exercise 782----20%
3.98K to 4.77K
04-Jan-19 4:01 PM
View: 
Smith Alan K.
EVP, Technical Operations
Bellicum Pharmaceuticals, Inc (BLCM) 03-Jan-19Option Exercise 1,562----44%
3.55K to 5.11K
04-Jan-19 4:02 PM
View: 
Spencer David M.
Chief Technology Officer
Bellicum Pharmaceuticals, Inc (BLCM) 03-Jan-19Option Exercise 1,562----2%
91.5K to 93.06K
04-Jan-19 4:03 PM
View: 
Williams Rosemary Y.
Principal Accounting Officer
Bellicum Pharmaceuticals, Inc (BLCM) 03-Jan-19Payment of Exercise 295$3.20$944.00(6%)
4.77K to 4.47K
89%
04-Jan-19 4:01 PM
View: 
Smith Alan K.
EVP, Technical Operations
Bellicum Pharmaceuticals, Inc (BLCM) 03-Jan-19Payment of Exercise 589$3.20$1,884.80(12%)
5.11K to 4.52K
89%
04-Jan-19 4:02 PM
View: 
Spencer David M.
Chief Technology Officer
Bellicum Pharmaceuticals, Inc (BLCM) 03-Jan-19Payment of Exercise 589$3.20$1,884.80(< 1%)
93.06K to 92.47K
89%
04-Jan-19 4:03 PM
View: 
Naeve Gregory S.
Chief Business Officer
Bellicum Pharmaceuticals, Inc (BLCM) 02-Jan-19Option Exercise 2,031----15%
13.4K to 15.43K
04-Jan-19 4:02 PM
View: 
Spencer David M.
Chief Technology Officer
Bellicum Pharmaceuticals, Inc (BLCM) 02-Jan-19Option Exercise 2,500----3%
89.94K to 92.44K
04-Jan-19 4:03 PM
View: 
Williams Rosemary Y.
Principal Accounting Officer
Bellicum Pharmaceuticals, Inc (BLCM) 02-Jan-19Payment of Exercise 483$3.33$1,608.39(11%)
4.47K to 3.98K
89%
04-Jan-19 4:01 PM
View: 
Smith Alan K.
EVP, Technical Operations
Bellicum Pharmaceuticals, Inc (BLCM) 02-Jan-19Payment of Exercise 883$3.33$2,940.39(20%)
4.43K to 3.55K
89%
04-Jan-19 4:03 PM
View: 
Naeve Gregory S.
Chief Business Officer
Bellicum Pharmaceuticals, Inc (BLCM) 02-Jan-19Payment of Exercise 993$3.33$3,306.69(6%)
15.43K to 14.44K
89%
04-Jan-19 4:02 PM
View: 
Spencer David M.
Chief Technology Officer
Bellicum Pharmaceuticals, Inc (BLCM) 02-Jan-19Payment of Exercise 942$3.33$3,136.86(1%)
92.44K to 91.5K
89%
04-Jan-19 4:03 PM
View: 
Williams Rosemary Y.
Principal Accounting Officer
Bellicum Pharmaceuticals, Inc (BLCM) 02-Jan-19Option Exercise 1,281----40%
3.19K to 4.47K
04-Jan-19 4:01 PM
View: 
Smith Alan K.
EVP, Technical Operations
Bellicum Pharmaceuticals, Inc (BLCM) 02-Jan-19Option Exercise 2,344----112%
2.09K to 4.43K
13-Nov-18 4:01 PM
View: 
Stonehouse Jon P
Director
Bellicum Pharmaceuticals, Inc (BLCM) 09-Nov-18Market Purchase 10,000$4.56$45,600.00100%
0 to 10.0K
(92%)
05-Sep-18 4:02 PM
View: 
Spencer David M.
Chief Technology Officer
Bellicum Pharmaceuticals, Inc (BLCM) 04-Sep-18Market Sale (Planned) 10,000$7.04$70,413.00(10%)
99.94K to 89.94K
95%
23-Aug-18 4:03 PM
View: 
Naeve Gregory S.
Chief Business Officer
Bellicum Pharmaceuticals, Inc (BLCM) 21-Aug-18Payment of Exercise 1,597$6.74$10,763.80(11%)
15.0K to 13.4K
95%